---
title: "Laxmi Dental Ltd (LAXMIDENTL) — Share Price, Financials & Analysis"
symbol: "LAXMIDENTL"
company: "Laxmi Dental Ltd"
canonical: "https://tapetide.com/stocks/LAXMIDENTL"
isin: "INE0WO601020"
nse_symbol: "LAXMIDENTL"
bse_code: "544339"
sector: "Healthcare"
industry: "Medical Equipment"
market_cap_cr: 1089.95
generated_at: "2026-09-13T19:21:31.760Z"
---

# Laxmi Dental Ltd (LAXMIDENTL)

Canonical page: https://tapetide.com/stocks/LAXMIDENTL

## Company

- **NSE Symbol:** LAXMIDENTL
- **BSE Code:** 544339
- **ISIN:** INE0WO601020
- **Sector:** Healthcare
- **Industry:** Medical Equipment
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-01-20
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** laxmidentallimited.com

## About

Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]

## Latest Price

- **Price:** ₹202.84
- **Change:** +0.28 (+0.14%)
- **Open:** ₹201.15
- **Day High:** ₹204
- **Day Low:** ₹197.01
- **Previous Close:** ₹202.56
- **Volume:** 52887
- **As Of:** 2026-09-11T10:24:59+00:00

## Key Fundamentals

Observed at 2026-09-11T04:46:44.845689Z.

- **Market Cap:** ₹1089.95 Cr
- **Classification:** Microcap
- **P/E (reported):** 36.1
- **P/E (TTM):** 36.16
- **EPS (TTM):** ₹5.61
- **Book Value:** ₹44.22
- **Price to Book:** 4.58
- **Dividend Yield:** 0%
- **ROE:** 12.16%
- **ROCE:** 16.33%
- **Debt to Equity:** 0.05
- **Revenue (yearly):** ₹271.5 Cr
- **Net Income:** ₹22.33 Cr
- **EBITDA:** ₹31.26 Cr
- **52-Week High:** ₹377.05
- **52-Week Low:** ₹155.88
- **RSI (14):** 50.7

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 89.47 | 9% |
| growth | 60.67 | 9% |
| momentum | 34.83 | 12% |
| ownership | 48.77 | 24% |
| quality | 48.12 | 22% |
| valuation | 32.32 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 103% CAGR over last 5 years

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Working capital days have increased from 77.3 days to 195 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 437.79% | 203.53% | 356.56% |
| ebitda margin growth | 6.38% | -40.16% | -14.55% | 132.02% |
| net income growth | 1.98% | -12.09% | 124% | 103% |
| revenue growth | 1.07% | 12% | 20% | 25% |
| roce | 7.4% | -18.31% | — | 1.29% |
| roe | 2.18% | -69.79% | 9.86% | -213.75% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| Expenses | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 | 60 | 60 |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 10 | 12 | 11 | 7 | 14 | 14 |
| OPM % | 8 | 21 | 23 | 15 | 16 | 16 | 18 | 15 | 11 | 18 | 19 |
| Other Income | 0 | 0 | 6 | 1 | 1 | 2 | 2 | 2 | -4 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -1 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | -1 | 11 | 12 |
| Tax % | -140 | 16 | 11 | 23 | 23 | 41 | 24 | 20 | -175 | 4 | 21 |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS in Rs | 74.05 | 243.91 | 6.04 | 2.12 | 0.93 | 0.78 | 1.53 | 1.55 | 0.36 | 1.83 | 1.87 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 150 | 92 | 137 | 162 | 194 | 239 | 278 | 287 |
| Expenses | 146 | 88 | 130 | 152 | 169 | 196 | 234 | 241 |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 43 | 46 |
| OPM % | 2.3 | 4.6 | 4.8 | 6 | 13 | 18 | 16 | 16 |
| Other Income | 2 | 0 | -10 | 2 | 0 | 10 | 3 | 3 |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 1 | 1 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 | 17 |
| Profit before tax | -4 | -4 | -16 | -5 | 7 | 31 | 29 | 31 |
| Tax % | 5 | 8 | 15 | 4 | -136 | 21 | 9 | — |
| Net Profit | -5 | -5 | -19 | -4 | 25 | 32 | 29 | 31 |
| EPS in Rs | -154.92 | -156.22 | -596.62 | -128.94 | 804.81 | 5.78 | 5.27 | 5.61 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 232 |
| Borrowings | 37 | 39 | 50 | 50 | 61 | 20 | 13 |
| Other Liabilities | 31 | 34 | 43 | 40 | 46 | 60 | 38 |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 294 |
| Fixed Assets | 39 | 42 | 40 | 40 | 46 | 51 | 63 |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 27 |
| Other Assets | 66 | 56 | 63 | 56 | 87 | 227 | 204 |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 294 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 12 | 10 | -2 | 14 | 8 | 44 | -5 |
| Cash from Investing Activity | -18 | -9 | 3 | -10 | -11 | -29 | -80 |
| Cash from Financing Activity | 6 | 0 | -4 | -1 | -3 | 111 | -18 |
| Net Cash Flow | 0 | 0 | -3 | 3 | -5 | 125 | -102 |
| Free Cash Flow | -5 | 0 | 0 | 5 | -5 | 28 | -23 |
| CFO/OP | 357 | 226 | -30 | 157 | 38 | 109 | 4 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 64 | 64 | 54 | 46 | 47 | 56 | 60 |
| Inventory Days | 186 | 305 | 272 | 212 | — | 397 | 97 |
| Days Payable | 197 | 273 | 245 | 197 | — | 585 | 47 |
| Cash Conversion Cycle | 54 | 96 | 81 | 61 | 47 | -132 | 109 |
| Working Capital Days | 13 | 3 | -3 | -13 | 0 | 37 | 195 |
| ROCE % | — | 3 | -1 | 1 | 18 | 19 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 86.61% | 41.7% | 41.7% | 41.7% | 41.7% | 41.77% | 41.8% |
| FIIs | 0% | 34.24% | 33.59% | 32.39% | 32.45% | 31.21% | 30.1% |
| DIIs | 0% | 12.86% | 14.31% | 11.85% | 10.83% | 10.52% | 10.89% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 6.49% | 5.8% | 9.26% | 10.18% | 11.52% | 11.82% |
| Others | 13.39% | 4.7% | 4.6% | 4.8% | 4.84% | 4.98% | 5.39% |
| No. of Shareholders | 13 | 29482 | 27957 | 37909 | 38635 | 38161 | 36937 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 6 / 4 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 198.49 | Buy |
| EMA (10) | 199.84 | Buy |
| SMA (20) | 197.75 | Buy |
| EMA (20) | 200.66 | Buy |
| SMA (50) | 209.28 | Sell |
| EMA (50) | 206.28 | Sell |
| SMA (100) | 213.75 | Sell |
| EMA (100) | 211.85 | Sell |
| SMA (200) | 216.29 | Sell |
| EMA (200) | 234.91 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 51.13 | Neutral |
| MACD (12,26,9) | -2.2 | Buy |
| Stochastic (14,3,3) | 87.86 | Sell |
| ADX (14) | 13.23 | Neutral |
| Williams %R (14) | -13.89 | Sell |
| ATR (14) | 6.07 | Neutral |
| ROC (12) | 3.38 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 63.77 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 2 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 2 analyst ratings, observed at 2026-09-11T04:46:44.842113+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39b0e3c6-7f29-405d-93a0-2122dcc33568.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df7b3434-bb79-4666-b1aa-9860897a2f08.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32c8b990-689d-49ff-a2f7-1bb50e3b9a10.pdf) |
| 2026-09-03 | [Intimation Of 22Nd Annual General Meeting (AGM) Scheduled To Be Held On Friday September 25 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33a47d9c-c09b-430d-af3e-07e436ce6cb8.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a19a55-3e3e-4c04-8f16-900338e12f1f.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc7cec9e-6335-4457-a2f8-24725df9fe4b.pdf) |
| 2026-08-31 | [Intimation Of Approval For Listing And Trading Of Further Issue Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=619912bc-671a-40ea-be0e-de1cbb0822b0.pdf) |
| 2026-08-27 | [Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday August 27 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c19c8b11-aef4-4779-9799-da760beddc6b.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43cfd84a-75e1-49f6-8fe6-991b87aee06e.pdf) |
| 2026-08-27 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a42d129-c757-4f83-98d9-b72bcd35dbef.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23282f37-866c-403f-b397-92d2d0935aa7.pdf) |
| 2026-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4feeb5d8-c7a0-4f52-b7c4-4b4b94382ddb.pdf) |
| 2026-02-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b131cb41-920b-492d-9159-6598029b0d15.pdf) |
| 2025-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a0e0ea6-76b6-4e79-ac75-d89d0a317580.pdf) |
| 2025-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f632afda-22da-4151-8374-b42ae2845d43.pdf) |
| 2025-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37543f87-e7af-4e3b-a6ba-8f405b5438b5.pdf) |
| 2025-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cb294eb-dc88-49a2-9a84-64b1926cb0e3.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Results - Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbf72444-884b-4cbd-a8db-0abf0ec61d63.pdf) |
| 2026-05-21 | [Results - Audited Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fa27cff-c3b5-4a96-b265-09170838d83c.pdf) |
| 2026-02-10 | [Results - Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0896d397-a5a2-4db4-a652-15087c2fa2a8.pdf) |
| 2025-11-11 | [Results - Financial Results For Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80b59ffb-d47d-431e-a56f-4ddd1ad9f9e3.pdf) |
| 2025-08-12 | [Financial Results For The Quarter Ended 30Th June 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5abadbe9-25e9-4646-9444-6aca2b60d5ab.pdf) |
| 2025-05-27 | [Financial Results For The Financial Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f879857-c44c-404b-bdbf-f0283cbce161.pdf) |
| 2025-02-13 | [Outcome Of Board Meeting-Financial Result](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c2aeab-b2e7-43b2-a1fd-7b743d1e1127.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f013c28-ee49-45b7-99d4-43478495a6e2.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3e06f8f-b397-4d94-a98a-e05bb6470037.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715799f7-825c-4cba-a978-957b5acc93eb.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e5744cc-87aa-4cfd-8862-34a839eb1fd6.pdf) |
| 2025-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c7b7dbe-8c44-4e16-925d-b44b96ccbcc3.pdf) |
| 2025-05-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db003772-82a4-4c7d-aaaa-24157f7399e9.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b17b74a3-0825-42c5-9e7d-5be52c6fd5f9.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39ac43ea-fb79-4429-89bb-7c18593416e1.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - NSE granted in-principle approval for listing 500,000 equity shares under ESOP 2024. | [Intimation Of In-Principle Approval For Listing Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024 9 Apr - NSE granted in-principle approval for listing 500,000 equity shares under ESOP 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e81406b-0b95-4fca-91a3-a94a67f37aa4.pdf) |
| 7 May - ICRA reports IPO proceeds utilization for quarter ended March 31, 2026, with no material deviation. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 7 May - ICRA reports IPO proceeds utilization for quarter ended March 31, 2026, with no material deviation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/48b23c94-7dea-4cfc-b0c7-6a69c8e2fd76.pdf) |
| 4 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/363c96ae-2f70-4dcc-b25b-83ab51ecc175.pdf) |
| 28 Feb - Promoter Sameer Merchant acquired 15,000 shares (0.03%) on Feb 27, 2026 via open market. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 28 Feb - Promoter Sameer Merchant acquired 15,000 shares (0.03%) on Feb 27, 2026 via open market.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59B9DF25_1326_4318_B94C_EF500C2321AF_104433.pdf) |
| 27 Feb - Investor meetings at Investec India Promoter & Founder Conference in Mumbai on March 11, 2026 (physical). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Feb - Investor meetings at Investec India Promoter & Founder Conference in Mumbai on March 11, 2026 (physical).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6157184-4c1c-493a-920f-16c98d91b482.pdf) |
| 26 Mar - Board approved scheme to amalgamate Bizdent Devices Pvt Ltd into Laxmi Dental; subject to statutory approvals; March 26, 2026. | [Surrender Of 32538 ESOP By Mr. Mitesh Kariya 26 Mar - Board approved scheme to amalgamate Bizdent Devices Pvt Ltd into Laxmi Dental; subject to statutory approvals; March 26, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/25b6c21d-d200-4ad3-9ca2-20a769a6adac.pdf) |
| 26 Mar - Board approved Scheme to amalgamate Bizdent Devices into Laxmi Dental (March 26, 2026); policy updates, auditors appointed, 32,538 ESOPs surrendered. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 26 Mar - Board approved Scheme to amalgamate Bizdent Devices into Laxmi Dental (March 26, 2026); policy updates, auditors appointed, 32,538 ESOPs surrendered.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ec0f212f-66fb-4fdf-9ec0-181e24ff68d7.pdf) |
| 26 Mar - Board approved amalgamation of Bizdent into Laxmi Dental; March 26, 2026; 32,538 ESOPs surrendered. | [Announcement under Regulation 30 (LODR)-Change in Management 26 Mar - Board approved amalgamation of Bizdent into Laxmi Dental; March 26, 2026; 32,538 ESOPs surrendered.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b76c3fbb-5eb8-4eb5-b86b-57ad772042f5.pdf) |
| 26 Feb - NDR on March 5, 2026 (11:00 AM) in Pune by Elara Capital; 1x1/group investor meetings. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Feb - NDR on March 5, 2026 (11:00 AM) in Pune by Elara Capital; 1x1/group investor meetings.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b76f6599-4aa4-4246-88fe-6bcda295d65d.pdf) |
| 17 Apr - Laxmi Dental to attend an NDR with investors in Chennai on April 22, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Apr - Laxmi Dental to attend an NDR with investors in Chennai on April 22, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/122f6be0-d67a-4698-baa8-96fc89eb8bb4.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a0e0ea6-76b6-4e79-ac75-d89d0a317580.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4feeb5d8-c7a0-4f52-b7c4-4b4b94382ddb.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4feeb5d8-c7a0-4f52-b7c4-4b4b94382ddb.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37543f87-e7af-4e3b-a6ba-8f405b5438b5.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b131cb41-920b-492d-9159-6598029b0d15.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/39ac43ea-fb79-4429-89bb-7c18593416e1.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cb294eb-dc88-49a2-9a84-64b1926cb0e3.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f632afda-22da-4151-8374-b42ae2845d43.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88b0f877-319c-4af5-be93-f6bc0987b9f8.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:21:31.760Z.